Vireo Health Announces Second Quarter 2019 Financial Results – Total revenue of $7.2 million increased 70 percent year-over-year – Voluntary share lock-up extensions approved by management and insiders –...
Ohio Medical Solutions will manufacture and wholesale Vireo-branded medical cannabis products to third-party dispensaries throughout the Buckeye State MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the...
Company is developing a vaporizer that allows consumers to customize their experience by utilizing multiple cartridges in one device MINNEAPOLIS, July 25, 2019 /PRNewswire/ — Vireo Health International, Inc....
With More than 25,000 Home Deliveries – Company Now Offers Free Same-Day Option NEW YORK, July 16, 2019 /PRNewswire/ — Vireo Health of New York (“Vireo” or the “Company”),...
Company plans cultivation and processing facility in San Juan area and six dispensaries throughout island MINNEAPOLIS, June 20, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the “Company”)...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
The American Cannabis Operator Index extended its post-March weakness this month, declining over 13% to 95.27: The index, which launched at the end of October with a value of 100, traded...
Vireo Health Announces First Quarter 2019 Financial Results Pro forma Q1 revenue of approximately $7.0 million Total revenue of $5.8 million increased approximately 57 percent year-over-year Minnesota passes law...
Rabin brings two decades of marketing and innovation experience in consumer healthcare and beverage alcohol industries NEW YORK, May 29, 2019 /PRNewswire/ — Vireo Health International, Inc. (CSE: VREO), a leading...
Company establishes U.S. governance standards with appointment of new directors and sub-committees MINNEAPOLIS, May 16, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo Health” or the “Company”) (CSE: VREO), a leading...
This is a copy of the May 12th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, “The next Tilray”. This was a phrase...
Exclusive Interview with Vireo Health Founder, Chairman, and CEO Dr. Kyle Kingsley Vireo Health (CSE: VREO) (OTC: VREOF) is one of the largest multi-state operators with a presence in...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
Vireo Health Announces Full Year 2018 Revenues of $18.5 Million with 70% Year-Over-Year Growth Company raised $51.4 million through reverse takeover transaction (RTO) in March Successful closing of five...
This is a copy of the April 28th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, On Day 1 of the Benzinga Cannabis...
Potential benefits associated with cannabinoid additives in tobacco products include the reduction of irritation, inflammation and carcinogenicity MINNEAPOLIS, April 25, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the “Company”)...
MINNEAPOLIS, March 20, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the Company”), America’s leading science-focused multi-state cannabis company, is pleased to announce that effective at market open...
